| Prognostic importance of the albumin to globulin ratio in metastatic gastric cancer patients Y Bozkaya, GU Erdem, NS Demirci, O Yazıcı, NY Özdemir, O Köstek, ... Current medical research and opinion 35 (2), 275-282, 2019 | 40 | 2019 |
| Oxaliplatin-induced acute thrombocytopenia GU Erdem, M Dogan, NS Demirci, N Zengin Journal of Cancer Research and Therapeutics 12 (2), 509-514, 2016 | 29 | 2016 |
| Small cell carcinoma of the urinary bladder: changing trends in the current literature GU Erdem, NY Özdemir, NS Demirci, S Şahin, Y Bozkaya, N Zengin Current Medical Research and Opinion 32 (6), 1013-1021, 2016 | 25 | 2016 |
| Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma NS Demirci, GU Erdem Bosnian Journal of Basic Medical Sciences 18 (3), 268, 2018 | 24 | 2018 |
| Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis Y Ergun, NY Ozdemir, EK Guner, E Esin, MA Sendur, EB Koksoy, ... J BUON 23 (7), 116-121, 2018 | 21 | 2018 |
| Comparative study of receptor discordance between primary and corresponding metastatic lesions in breast cancer GU Erdem, K Altundag, NY Ozdemir, S Sahin, NS Demirci, F Karatas, ... J buon 22 (2), 365-376, 2017 | 19 | 2017 |
| 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum … GU Erdem, Y Bozkaya, NY Ozdemir, NS Demirci, O Yazici, N Zengin Bosnian journal of basic medical sciences 18 (2), 170, 2018 | 17 | 2018 |
| Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach Y Bozkaya, GU Erdem, NY Ozdemir, NS Demirci, C Hocazade, O Yazıcı, ... Current Medical Research and Opinion 33 (1), 109-116, 2017 | 17 | 2017 |
| Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma Y Bozkaya, NS Demirci, A Kurtipek, GU Erdem, NY Ozdemir, N Zengi̇ Molecular and clinical oncology 7 (2), 267-274, 2017 | 16 | 2017 |
| Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer? NS Demirci, M Dogan, GU Erdem, S Kacar, T Turhan, S Kilickap, ... Saudi Journal of Gastroenterology 23 (3), 183-189, 2017 | 16 | 2017 |
| Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a … NS Demirci, S Aksoy, NY Özdemir, GU Erdem, M Ozcelik, E Tanrikulu, ... Current Medical Research and Opinion 33 (3), 401-407, 2017 | 15 | 2017 |
| The clinical and pathological features affecting the time of relapse in patients with early stage colorectal cancer D Yazilitas, N Özdemir, C Hocazade, NS Demirci, N Zengin Journal of cancer research and therapeutics 12 (4), 1257-1260, 2016 | 15 | 2016 |
| The relationship between symptom severity and caregiver burden in cancer patients under palliative care: A cross-sectional study E Celik, MS Aslan, N Sengul Samanci, M Karadag, T Saglam, ... Journal of Palliative Care 37 (1), 48-54, 2022 | 13 | 2022 |
| Clinical predictive factors associated with pathologic complete response in locally advanced rectal cancer Y Bozkaya, NY Özdemir, GU Erdem, EK Güner, Y Ürün, NS Demirci, ... Journal of Oncological Sciences 4 (1), 5-10, 2018 | 12 | 2018 |
| Mortality risk analysis of asymptomatic and symptomatic venous thromboembolism in patients with metastatic colorectal cancer Y Bozkaya, N Özdemir, GU Erdem, NS Demirci, C Hocazade, N Zengin Journal of cancer research and therapeutics 14 (6), 1330-1335, 2018 | 9 | 2018 |
| Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy E Değerli, N Şentürk Öztaş, G Alkan, Ş Bedir, S Derin, N Valıkhanova, ... Journal of Chemotherapy 35 (1), 29-38, 2023 | 8 | 2023 |
| Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy? Y Bozkaya, NY Özdemir, S Sezer, O Köstek, NS Demirci, O Yazıcı, ... Cancer Biomarkers 22 (1), 143-149, 2018 | 8 | 2018 |
| Loss of skeletal muscle area and fat-free mass during dabrafenib/trametinib and vemurafenib/cobimetinib treatments in patients with BRAF-mutant metastatic malignant melanoma NS Samanci, E Çelik, O Bagcilar, BC Erol, E Bicki, K Oruc, S Bedir, ... Melanoma Research 30 (5), 477-483, 2020 | 7 | 2020 |
| A rare case: Branch retinal vein occlusion associated with the use of tamoxifen NS Demirci, GU Erdem, Nİ Uçgun, Y Bozkaya, NY Ozdemir, M Dogan, ... Journal of Cancer Research and Therapeutics 15 (3), 722-724, 2019 | 7 | 2019 |
| Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology H Odabas, A Ulas, K Aydin, M Inanc, A Aksoy, D Yazilitas, M Turkeli, ... Tumor Biology 36, 9641-9648, 2015 | 7 | 2015 |
